Bigyan is the SVP/Head of Business Strategy and Development at Enveda Biosciences. Enveda is using its discovery platform, which is based on metabolomics, machine learning and robotics, to unearth new medicines from its first-of-a-kind chemical map of the natural world, and boasts a rich and deep pipeline of first-in-class and best-in-class assets across multiple therapeutic areas. Bigyan brings over a decade of experience in biomedical research (MIT), biopharma strategy (Clarion Healthcare and AstraZeneca), and biotech investing in both private and public companies (Rock Springs Capital), and will be available at BIO for partnering discussions.